Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The Aetion Evidence Platform® provides essential real-world evidence tailored for life sciences companies, payers, and risk-bearing providers. Our mission is to tackle significant healthcare inquiries: identifying the most effective treatments, determining their ideal patient populations, and establishing the optimal timing for their application. This approach directly translates into improved decision-making. Serving as a collaborator to many of the leading 20 global biopharma companies, prominent payers, and the FDA, Aetion plays a pivotal role in shaping the most vital decisions within the industry. Our transparent analytical methods facilitate advancements in product development, commercialization strategies, and payment innovations, steering healthcare into a new age. By transitioning the use of real-world evidence from merely descriptive analytics to deriving causal insights, the Aetion Evidence Platform is at the forefront of this evolution. Furthermore, we provide timely answers within a matter of days or weeks, delivering the swift results necessary to enhance both clinical and financial outcomes. Make the most of your available data by transforming it into actionable insights that can be utilized immediately for better healthcare solutions.
Description
Behavioral health constitutes a crucial yet frequently neglected component of overall wellness. The impact of mental and substance use disorders affects an astonishing 970 million individuals globally, contributing to an economic burden exceeding US $1 trillion each year. In spite of this escalating crisis, advancements in treatment and understanding have not kept pace with other medical fields. Alarmingly, less than half of those suffering from major depression, which is the most prevalent mental health disorder, achieve remission with existing therapies. Increased awareness has sparked a greater demand for services in a system that remains ill-equipped to address the extensive complexities of this need. There exists a significant evidence gap that hinders progress in research and innovation, largely due to the inherent challenges within behavioral health, such as intricate disease causes, a shortage of measurable biomarkers, and fragmented institutional approaches. Even after many years of dedicated research, we remain largely in the dark about how to effectively treat most behavioral health conditions, indicating a critical need for renewed focus and resources in this field. Ultimately, bridging this gap is essential for improving the lives of millions affected by these disorders.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Aetion
Founded
2012
Country
United States
Website
aetion.com
Vendor Details
Company Name
Holmusk
Founded
2015
Country
Singapore
Website
www.neuroblu.ai/